BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Bayhill Therapeutics, Inc. 

3400 West Bayshore Road

Palo Alto  California  94303  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Bayhill Therapeutics, Inc. Announces the Successful Clearance of an IND for BHT-3034 for the Treatment of Myasthenia Gravis 3/2/2011 9:12:02 AM    More...
Bayhill Therapeutics, Inc. to Present Correlation of Antibodies with Clinical Response to Treatment with BHT-3009 in Multiple Sclerosis 10/14/2010 8:09:10 AM    More...
Bayhill Therapeutics, Inc. Enters Exclusive, Worldwide Collaboration with Genentech, Inc. (DNA) (JOBS) for BHT-3021 in Type 1 Diabetes; Deal Could Potentially Exceed $350M 6/10/2009 7:22:53 AM    More...
Bayhill Therapeutics, Inc. Founder Lawrence Steinman, M.D. Recognized for Leadership in Multiple Sclerosis 3/16/2009 10:01:06 AM    More...
Bayhill Therapeutics, Inc. to Participate in Interactive Workshop at BIO-Europe Spring(R) 2009 3/12/2009 8:49:30 AM    More...
Bayhill Therapeutics, Inc. to Present Phase II Follow-up Data on BHT-3009 for Treatment of Multiple Sclerosis 3/9/2009 8:49:19 AM    More...
Bayhill Therapeutics, Inc. and The Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes 10/30/2008 10:25:25 AM    More...
Bayhill Therapeutics, Inc. Withdraws IPO Plans 6/30/2008 7:07:18 AM    More...
Bayhill Therapeutics, Inc. Presents Data From a Phase II Trial of BHT-3009 in Multiple Sclerosis at American Academy of Neurology 60th Annual Meeting 4/17/2008 10:02:56 AM    More...
Bayhill Therapeutics, Inc. Announces Presentation of MS Drug Candidate BHT-3009 at American Academy of Neurology 60th Annual Meeting 4/11/2008 8:59:01 AM    More...
123

//-->